• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of optically active radioligand for biomedical imaging of neurotrasmission

Research Project

Project/Area Number 10470474
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Physical pharmacy
Research InstitutionKYOTO UNIVERSITY

Principal Investigator

SAJI Hideo  Kyoto University, Graduate School of Pharmaceutical Sciences, Professor, 薬学研究科, 教授 (40115853)

Co-Investigator(Kenkyū-buntansha) OHMOMO Yoshiro  Osaka University of Pharmaceutical Sciences, Associate Professor, 助教授 (70183241)
MAGATA Yasuhiro  Kyoto University, Graduate School of Pharmaceutical Sciences, Associate Professor, 薬学研究科, 助教授 (20209399)
Project Period (FY) 1998 – 1999
Project Status Completed (Fiscal Year 1999)
Budget Amount *help
¥10,600,000 (Direct Cost: ¥10,600,000)
Fiscal Year 1999: ¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 1998: ¥7,600,000 (Direct Cost: ¥7,600,000)
KeywordsBrain / Nicotine receptor / Monoamine oxidase / Radioligand / Bioimaging / In vivo mapping / Benzodiazepine receptor / Optical isomer / 脳 / 放射性リガンド / ラジオレセプターアッセイ / 体内分布 / 構造-活性相関 / ポジトロンCT / シングルフォトンCT / 酵素結合 / 脳局所分布
Research Abstract

Dynamic biological imaging using nuclear medical imaging technique and the radioligand is effective for elucidation of the process of neurotransmission. In this study, the superior radiation properties of 123-I for nuclear medical imaging promoted us to synthesize a radioiodinated compound as a radioligand for imaging. In the molecular design, particular attention was given to optical isomerism since there are cases where a great difference for the affinity for receptors and enzymes is observed between optical isomers. To evaluate the activity of monoamine oxidase (MAO) in vivo, we synthesized a clorgyline analog iodinated at 6-position (6ICG) for MAO A and a Ro 16-6491 analogs iodinated 4-position (4Ro) for MAO B, respectively. Each compound showed a high affinity and selectivity for a corresponding enzyme. Furthermore, a good correlation was observed between the cerebral uptake of radioactivity after injection of radioligand and enzymatic activity. For the imaging of nicotinic cholinergic receptors, a radioiodinated nicotine analog iodinated at 5-position of the pyridine ring,5-iodo-A85380 (5IA) was synthesized and the obtained 5IA was evaluated as a potential radioligand for investigating brain nicotinic receptors. The results of binding affinity experiments revealed that the affinity of 5IA was 10-fold higher than that of (S)-nicotine. Regional cerebral distribution studies in mice and rats disclosed that the accumulation of 125-I-5IA was dense in the thalamus, intermediate in the cortex and less marked in the cerebellum. The marked regional cerebral distribution was reduced and uniformalized by the treatment with cytidine. Gathered data indicate that radioiodinated 6ICG, 4Ro, and 5IA are potential radioligands for in vivo imaging studies of cerebral neurotransmission.

Report

(3 results)
  • 1999 Annual Research Report   Final Research Report Summary
  • 1998 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] 佐治 英郎: "放射性診断薬の開発の現状と新しい動向"先端医療. 5(2). 45-49 (1998)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H.Saji: "Targeted delivery of radiolabeled imaging and therapeutic agents: Bifunctional radiopharmaceutical."Critical Reviews in Therapeutic Drug Carrier Systems. 16(2). 209-244 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y.Magata: "Effect of chronic (-)nicotine treament on rat cerebral benzodiazepine receptors."Nucl.Med.Biol... 27(1). 57-60 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Saji: "Present state and furture of radio-pharamceuticals."Sentaniryou. 5 (2). 45-49 (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] H. Saji: "Targeted delivery of radiolabeled imaging and therapeutic agents : Bifunctional radiopharamceutiacal."Critical Reviews in Therapeutic Drug Carrier Systems. 16 (2). 209-244 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Y.Magata, et al.: "Effect of chronic (-) nicotine treatment on rat cerebral benzodiazepine receptors."Nucl. Med. Biol. 27 (1). 57-60 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1999 Final Research Report Summary
  • [Publications] Hideo Saji: "Targeted derivery of radiolabeled imaging and therapeutic agents : bifunctuional radiopharmaceuticals"Critical Rev. Ther. Drug Carrier Systems.. 16(2). 209-244 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Norio Yamamura: "Evaluation of radioiodinated medium chain fatty acids as new diagnostic agents for the determination of hepatic viabillity"Eur. J. Nucl. Med.. 26(12). 1597-1605 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Mikako Ogawa: "Synthesis, in vivo binding profile and biodistribution of a 125-I-labeled nicotine derivative: a potential radioligand for mapping nicotinic receptors"Jap. J. Nucl. Med.. 36(6). 651-651 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Yasuhiro Magata: "Effect of chronic (-)-Nicotine treatment on rat cerebral benzodiazepine receptors"Nucl. Med. Biol. 27(1). 50-57 (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] 佐治 英郎: "オピオイドレセプターのイメージング" 脳の科学. 20. 239-245 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] T.Mukai: "Pharmacokinetic models to evaluate rediolebeling reagents for protein rediopharmaceuticals." Nucl.Med.Biol.25(1). 31-36 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] Y.Arano: "Assessment of the radiochemical design of antibodies with a metabolizable linkage for target-selective redioactivity delivery" Bioconjugate Chem.9(4). 497-506 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] N.Yamamura: "Evaluation of〔1-^<11>C〕octanoate as a new rediopharmaceutical for assessing liver function using positron emission tomography." Nucl.Med.Biol.25(4). 467-472 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] E.Tadamura: "Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy" J.Nucl.Med.39(2). 390-396 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 佐治 英郎: "放射性診断薬の開発の現状と新しい動向" 先端医療. 5(2). 45-49 (1998)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi